Back to search

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: A six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

Data up to Jan 2025

Published2001
Citations247
References18

Total Citations Per Year

Abstract

References (18)

Evaluation of Diagnostic Criteria for Ankylosing Spondylitis

1984 • 5,334 citations

Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)

1997 • 1,901 citations

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index

2001 • 1,789 citations

Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis

1999 • 812 citations

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison

1999 • 549 citations

Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.

1992 • 471 citations

Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial

1999 • 357 citations

Ketoprofen: A Review of Its Pharmacologic and Clinical Properties

1986 • 293 citations

Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.

1999 • 283 citations

Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.

1997 • 243 citations

Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial

1999 • 158 citations

THE RELATIONSHIP OF CLINICAL AND LABORATORY MEASUREMENTS TO RADIOLOGICAL CHANGE IN ANKYLOSING SPONDYLITIS

1991 • 95 citations

Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis.

1999 • 82 citations

Magnetic resonance imaging in musculoskeletal disorders.

1987 • 66 citations

Current Guidelines for the Drug Treatment of Ankylosing Spondylitis

1998 • 54 citations

Ximoprofen in Ankylosing Spondylitis:A Double Blind Placebo Controlled Dose Ranging Study

1994 • 43 citations

Ketoprofen

1974 • 20 citations

Diagnosis and monitoring of spondylarthropathy.

1990 • 14 citations

Cited By (0)

Loading...
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of… (2001) – Arthritis & Rheumatism | Metascience Observatory Explorer